Skip to main content
. 2024 Jul 12;15:1382120. doi: 10.3389/fphar.2024.1382120

FIGURE 5.

FIGURE 5

Cost-effectiveness Acceptability Curves and Incremental Cost-effectiveness Scatterplots of Scenario Analysis (A) Cost-effectiveness acceptability curves of T-DXd in comparison with T-DM1. (B) Incremental cost-effectiveness scatterplots of T-DXd in comparison with T-DM1. Abbreviations: WTP, willingness to pay; QALY, quality-adjusted life year; T-DM1, T-DMI; T-DXd, trastuzumab deruxtecan.